Back to all Programs

Past Event

Related Materials

Past Event

RespiDART 2018

RV521: A new and potent RSV fusion inhibitor in clinical development | Stuart Cockerill, PhD

Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD

3D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhD

Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD

Cocrystal Pharma: Influenza drug pipeline design | Sam Lee, PhD